肺抑瘤合剂治疗ⅢB、Ⅳ期肺腺癌的临床研究.pdfVIP

调整机体免疫功能，降低血清VEGF水平，抑制肿瘤血管形成。为中医综合治疗ⅢB、 Ⅳ期肺癌提供了临床及理论依据，更好的指导临床ⅢB、Ⅳ期肺腺癌的治疗。 关键词 肺抑瘤合剂；ⅢB、Ⅳ期肺腺癌；临床疗效 Clinical Study on the effect of lung tumor-liquid for ⅢB, Ⅳperiod lung adenocarcinoma Specialty：The Study of Lung Disease ．Internal Medicine of TCM Author ：Zhao Yue Tutor ：Prof 、Zheng Xin Abstract Objeftive:To study the clinical effect of lung tumor-liquid forⅢB,Ⅳperiod lung adenocarcinoma and discusses the may function mechanism,and provide the theory and clinical evidence for traditional Chinese medicine of ⅢB, Ⅳperiod lung adenocarcinoma Methods: 120 cases of the selected patients were randomly divided into Chinese traditional medicine group (group A 30 cases), Chinese medicine and immune support group (group B 30 cases),brucea javanica oil and immune support group (group C 30 cases), chemotherapy and immune support group (group D 30 cases).28 days a cycle, after four treatment cycle to observe the changes in lesions ,the main symptoms (fever, cough, haemoptysis, chest pain, shortness of breath, etc) change, surial comparison, life KPS score more state, weight index, immune index, the level of serum VEGF changes. Results ：Lesions change: the rank and inspection, the focus of the four groups of patients was statistically significant changes (P 0.05), D group of patients with the most obvious, group A,B is the second smallest, and are better than group C; main symptoms change: the main symptoms change after treatment were significant (P 0.05), indicating that four treatment methods are valid, A, B groups are optimal, D group is the second smallest, and are better than group C; The quality of life: the four groups of patients before and after treatment by the rank and inspection KPS ratings are statistically significant (P 0.05), A, B and C